German drugmaker BioNTech, known for its COVID-19 vaccine developed with Pfizer, is facing a significant decline in vaccine sales. This has resulted in a substantial increase in losses during the second quarter, quadrupling compared to …
Continue readingTag: Drug Development
Bristol Myers Squibb Beats Expectations on New Drug Growth
Bristol Myers Squibb (BMS) has reported strong second-quarter earnings, exceeding analyst expectations. The pharmaceutical giant’s success is attributed to the robust performance of its new drugs, including Reblozyl and Camzyos, as well as its top-selling …
Continue reading